Cover Image
市場調查報告書

潰瘍性結腸炎 (UC):主要20個市場的預測 2016-2026年

Ulcerative Colitis Forecast in 8 Major Markets 2016-2026

出版商 Black Swan Analysis 商品編碼 353261
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
潰瘍性結腸炎 (UC):主要20個市場的預測 2016-2026年 Ulcerative Colitis Forecast in 8 Major Markets 2016-2026
出版日期: 2016年03月01日 內容資訊: 英文 42 Pages
簡介

潰瘍性大腸炎 (UC) 是在結腸中引起慢性發炎的發炎性腸道疾病 (IBD) ,當作自體免疫疾病處理。和克隆氏症有幾個特徵相同,不過,UC是無症候期間分散的斷斷續續的疾病。這個疾病包含到結腸的直腸,依照患病直腸的長度分類。

本報告提供主要8個市場 (美國、法國、德國、義大利、西班牙、英國、巴西以及日本)的潰瘍性結腸炎 (UC) 的目前患者數 (性別、各年齡世代) 調查分析,目前盛行率,加上疾病概要,危險因素,疾病診斷預後,主要的症狀和併發症等系統性資訊

圖表

簡介

病因

危險因素和預防

疾病診斷

變異:地區/各民族

疾病預後和臨床過程

疾病相關的主要併發症/特徵

定量化做患者數的手法

週邊動脈疾病 (PAD) 的盛行率top line

潰瘍性結腸炎 (UC) 患者的特徵

  • 重病度及UC病變部位
  • UC進展的要素

潰瘍性結腸炎 (UC) 的相關疾病

  • 骨骼相關疾病
  • 皮膚科相關疾病
  • 消化系相關疾病
  • 血液、蛋白質相關疾病

簡稱

相關出版

患者為基礎的線上資料庫

患者為基礎的產品

價格的線上資料、平台

參考文獻

附錄

目錄
Product Code: ULCO0010216

image1

Ulcerative Colitis (UC) is an inflammatory bowel disease (IBD) causing chronic inflammation in the colon, and is treated as an autoimmune disease. While sharing some features with Crohn's disease, UC is an intermittent disease with periods of symptoms interspersed with asymptomatic periods (generally induced by response to treatment). The disease involves the rectum up to the colon and is classified according to length of colon affected.

This report provides the current prevalent population for Ulcerative Colitis across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ulcerative Colitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Ulcerative Colitis include:

  • Anaemia
  • Gastritis
  • Colorectal cancer
  • Osteoporosis
  • Complications from surgery
  • Pouchitis
  • Toxic megacolon
  • Extra-intestinal features (e.g. primary sclerosing cholangitis, erythema nodosum)

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Ulcerative Colitis's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Ulcerative Colitis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Ulcerative Colitis's prevalent population.
  • Identify sub-populations within Ulcerative Colitis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Ulcerative Colitis patients.

Coverage

US, UK, FR, DE, IT, ES, JP, BR

image2

Table of Contents

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions /Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Prevalence for Ulcerative Colitis

Features of Ulcerative Colitis Patients

  • Severity and Type of Involvement in UC
  • Contributing Factors to UC Development

Associated Conditions of Ulcerative Colitis

  • Skeletal Associated Conditions
  • Dermatological Associated Conditions
  • Digestive System Related Conditions
  • Haematological & Protein Conditions

Abbreviations used in the Report

Other Black Swan Analysis Publications

Black Swan Analysis Online Patient-Based Databases

Patient-Based Offering

Online Pricing Data and Platforms

References

Appendix

List of Tables

  • Severity index for adult UC patients
  • Prevalence of Ulcerative Colitis, total (000s)
  • Prevalence of Ulcerative Colitis, males (000s)
  • Prevalence of Ulcerative Colitis, females (000s)
  • Extent of involvement at diagnosis in Ulcerative Colitis patients, total (000s)
  • Severity of Ulcerative Colitis at diagnosis in patients, total (000s)
  • Smoking status of Ulcerative Colitis patients, total (000s)
  • Ulcerative Colitis patients with family history of UC, total (000s)
  • Prevalence of osteoporosis in Ulcerative Colitis patients, total (000s)
  • Prevalence of peripheral arthritis in Ulcerative Colitis patients, total (000s)
  • Prevalence of ankylosing spondylitis in Ulcerative Colitis patients, total (000s)
  • Prevalence of oral ulcerations in Ulcerative Colitis patients, total (000s)
  • Prevalence of pyoderma gangrenosum in Ulcerative Colitis patients, total (000s)
  • Prevalence of primary sclerosing cholangitis in Ulcerative Colitis patients, total (000s)
  • Prevalence of gastritis in Ulcerative Colitis patients, total (000s)
  • Type of gastritis in Ulcerative Colitis patients, total (000s)
  • Prevalence of anaemia in Ulcerative Colitis patients, total (000s)
  • Prevalence of elevated CRP in Ulcerative Colitis patients, total (000s)
  • Prevalence of elevated ESR in Ulcerative Colitis patients, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • USA Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
  • France Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • France Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • Germany Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • Italy Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • Spain Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • United Kingdom Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
  • Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, males (000s)
  • Japan Prevalence of Ulcerative Colitis by 5-yr age cohort, females (000s)
Back to Top